| Bioactivity | Cinitapride monotartrate is a 5-HT1A and 5-HT4 agonist. Cinitapride monotartrate is also a 5-HT2A and D2 antagonist. Cinitapride monotartrate can be used for the research of functional dyspepsia[1][2]. |
| In Vivo | Cinitapride (intraperitoneal injection; 0.25-1 mg/kg; once) shows gastroprotective effetcs in gastric ulceration rat model[2]. Animal Model: |
| Name | Cinitapride monotartrate |
| CAS | 1207859-16-2 |
| Formula | C25H36N4O10 |
| Molar Mass | 552.57 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Du Y, et al. Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia. J Clin Gastroenterol. 2014 Apr;48(4):328-35. [2]. Alarcón de la Lastra C, et al. Effects of cinitapride on gastric ulceration and secretion in rats. Inflamm Res. 1998 Mar;47(3):131-6. [3]. Parthena MARTIN, et al. Compositions and methods for treating seizure disorders. Patent WO2018060732A2. |
Cinitapride monotartrate
CAS: 1207859-16-2 F: C25H36N4O10 W: 552.57
Cinitapride monotartrate is a 5-HT1A and 5-HT4 agonist. Cinitapride monotartrate is also a 5-HT2A and D2 antagonist. Cin
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.